Trump's nomination of Robert F. Kennedy Jr. as Secretary of Health and Human Services, announced November 14, anchors trader consensus at 73.5% against him being "out" by year-end, reflecting expectations of sustained support amid the incoming administration's transition. Recent Senate pushback from figures like Sen. Bill Cassidy over Kennedy's vaccine skepticism has surfaced, but GOP control of the chamber and Trump's public endorsements signal low near-term removal risk. No official withdrawal or firing signals have emerged, with confirmation hearings not slated until post-January 20 inauguration, leaving ample runway for retention despite ongoing vetting scrutiny. Markets price in historical precedent of presidents defending controversial picks early in terms.
Resumen experimental generado por IA con datos de Polymarket · ActualizadoAn announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Mercado abierto: Mar 19, 2026, 2:02 PM ET
Resolver
0x65070BE91...An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...Trump's nomination of Robert F. Kennedy Jr. as Secretary of Health and Human Services, announced November 14, anchors trader consensus at 73.5% against him being "out" by year-end, reflecting expectations of sustained support amid the incoming administration's transition. Recent Senate pushback from figures like Sen. Bill Cassidy over Kennedy's vaccine skepticism has surfaced, but GOP control of the chamber and Trump's public endorsements signal low near-term removal risk. No official withdrawal or firing signals have emerged, with confirmation hearings not slated until post-January 20 inauguration, leaving ample runway for retention despite ongoing vetting scrutiny. Markets price in historical precedent of presidents defending controversial picks early in terms.
Resumen experimental generado por IA con datos de Polymarket · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes